AstraZeneca to Make $2 Billion Manufacturing Investment in Maryland

Dow Jones

Nov 22

By Elias Schisgall

AstraZeneca is planning to make a $2 billion investment to expand its manufacturing footprint in Maryland.

The pharmaceutical company said Friday the investment will be for the construction of a new laboratory in Gaithersburg, Md., and to expand its existing facility in Frederick. The investment will create 1,900 construction jobs and 300 new, high-skilled positions across both projects.

The new commitment is part of AstraZeneca's pledge in July to invest $50 billion in U.S. operations. The company has already put capital toward new facilities in Rockville and in Virginia, as well as expanding an existing facility in Coppell, Texas.

Expansion of the Frederick facility will double the company's capacity to manufacture biologics and allow for the production of medicines across its rare disease portfolio.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

November 21, 2025 14:42 ET (19:42 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2585123508"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2585123508\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2585123508?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-22 03:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2585123508","market":"sh","top_or_hot":-1,"title":"AstraZeneca to Make $2 Billion Manufacturing Investment in Maryland","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  AstraZeneca is planning to make a $2 billion investment to expand its manufacturing footprint in Maryland. \n</p>\n<p>\n  The pharmaceutical company said Friday the investment will be for the construction of a new laboratory in Gaithersburg, Md., and to expand its existing facility in Frederick. The investment will create 1,900 construction jobs and 300 new, high-skilled positions across both projects. \n</p>\n<p>\n  The new commitment is part of AstraZeneca's pledge in July to invest $50 billion in U.S. operations. The company has already put capital toward new facilities in Rockville and in Virginia, as well as expanding an existing facility in Coppell, Texas. \n</p>\n<p>\n  Expansion of the Frederick facility will double the company's capacity to manufacture biologics and allow for the production of medicines across its rare disease portfolio. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 21, 2025 14:42 ET (19:42 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca to Make $2 Billion Manufacturing Investment in Maryland</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca to Make $2 Billion Manufacturing Investment in Maryland\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-22 03:42</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  AstraZeneca is planning to make a $2 billion investment to expand its manufacturing footprint in Maryland. \n</p>\n<p>\n  The pharmaceutical company said Friday the investment will be for the construction of a new laboratory in Gaithersburg, Md., and to expand its existing facility in Frederick. The investment will create 1,900 construction jobs and 300 new, high-skilled positions across both projects. \n</p>\n<p>\n  The new commitment is part of AstraZeneca's pledge in July to invest $50 billion in U.S. operations. The company has already put capital toward new facilities in Rockville and in Virginia, as well as expanding an existing facility in Coppell, Texas. \n</p>\n<p>\n  Expansion of the Frederick facility will double the company's capacity to manufacture biologics and allow for the production of medicines across its rare disease portfolio. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 21, 2025 14:42 ET (19:42 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2585123508","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2585123508","pubTimestamp":1763754120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"AstraZeneca is planning to make a $2 billion investment to expand its manufacturing footprint in Maryland.The pharmaceutical company said Friday the investment will be for the construction of a new laboratory in Gaithersburg, Md., and to expand its existing facility in Frederick. The investment will create 1,900 construction jobs and 300 new, high-skilled positions across both projects.The new commitment is part of AstraZeneca's pledge in July to invest $50 billion in U.S. operations. The company has already put capital toward new facilities in Rockville and in Virginia, as well as expanding an existing facility in Coppell, Texas.Expansion of the Frederick facility will double the company's capacity to manufacture biologics and allow for the production of medicines across its rare disease portfolio.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","BK4588":"碎股","BK4568":"美国抗疫概念","BK4585":"ETF&股票定投概念","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","AZN":"阿斯利康"},"translate_title":"阿斯利康将在马里兰州投资20亿美元制造业","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":0.9},"content_text":"By Elias Schisgall \n\n\n \n\n\n  AstraZeneca is planning to make a $2 billion investment to expand its manufacturing footprint in Maryland. \n\n\n  The pharmaceutical company said Friday the investment will be for the construction of a new laboratory in Gaithersburg, Md., and to expand its existing facility in Frederick. The investment will create 1,900 construction jobs and 300 new, high-skilled positions across both projects. \n\n\n  The new commitment is part of AstraZeneca's pledge in July to invest $50 billion in U.S. operations. The company has already put capital toward new facilities in Rockville and in Virginia, as well as expanding an existing facility in Coppell, Texas. \n\n\n  Expansion of the Frederick facility will double the company's capacity to manufacture biologics and allow for the production of medicines across its rare disease portfolio. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2025 14:42 ET (19:42 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}